Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia. In response to clinical confusion regarding the appropriate dose of amoxicillin-clavulanate, we have developed guidelines for the appropriate dosing of this second-line agent. For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily.

Original publication

DOI

10.4269/ajtmh.2008.78.208

Type

Journal article

Journal

The American journal of tropical medicine and hygiene

Publication Date

02/2008

Volume

78

Pages

208 - 209

Addresses

Department of Medicine, University of Melbourne, Melbourne, Australia. allen.cheng@menzies.edu.au

Keywords

Humans, Melioidosis, Pregnancy Complications, Infectious, Amoxicillin-Potassium Clavulanate Combination, Anti-Bacterial Agents, Administration, Oral, Infusions, Intravenous, Drug Administration Schedule, Pregnancy, Adult, Child, Female, Practice Guidelines as Topic